As well as being a Partner and heading up the firm’s portfolio management strategy, Luke sits in the Future of Health investment team, helping identify and invest in the next generation of companies that will revolutionise the health landscape.
Luke joined Octopus Ventures in 2009 but began his career as a scientist, working to understand human disease using computational methods and big data, revealing the role that evolution played in disease development, before transitioning to Management and Technology Consultancy, specialising in the Capital Markets.
Alongside his role at Octopus, Luke is Chairman of UMI3, the University of Manchester’s technology transfer office. He also sits on the University’s Global Leadership Board. Luke holds a BSc (hons) in Biochemistry and Biotechnology, an MSc in Computational Biology and a PhD in Computational Genetics, all from the University of Manchester. When not at work, Luke likes to spend his time travelling, eating, training and doing stuff involving cars.